PFBT
RXST icon

Parkside Financial Bank & Trust’s RxSight RXST Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$782 – 2771
2025
Q4 		$782 Sell
75
-500
-87% -$5.02K ﹤0.01% 2420
2025
Q3 		$5.16K Buy
575
+75
+15% +$658 ﹤0.01% 1725
2025
Q2 		$6.49K Sell
500
-30
-6% -$451 ﹤0.01% 1624
2025
Q1 		$13.4K Buy
530
+30
+6% +$892 ﹤0.01% 1301
2024
Q4 		$17.2K Hold
500
– – ﹤0.01% 1129
2024
Q3 		$24.7K Buy
+500
New +$25.6K ﹤0.01% 999

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Parkside Financial Bank & Trust's RXST Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of RxSight (RXST) in Q1 2026, closing a stake of 75 shares — an estimated $782 sold.

Parkside Financial Bank & Trust first reported a position in RXST in Q3 2024 and held it in 6 quarters. The position peaked at $24.7K in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 75 RxSight shares in Q1 2026, an estimated $782.
  • Parkside Financial Bank & Trust first reported a position in RxSight in Q3 2024 and held it in 6 quarters.
  • Parkside Financial Bank & Trust's RxSight position peaked at $24.7K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.